Poly-ADP-Ribose-Polymerase Inhibition Ameliorates Hind Limb Ischemia Reperfusion Injury in a Murine Model of Type 2 Diabetes
Chandler A. Long(Duke University), Michael T. Watkins(University of Illinois Chicago), Valy Boulom(Sinai Hospital), Rahmi Öklü(Brigham and Women's Hospital), Shirling Tsai(University of Tennessee Medical Center), Hassan Albadawi(Harvard University), Mitchell H. Goldman(University of Tennessee at Knoxville), Hyung‐Jin Yoo(University of Tennessee Medical Center)
Cited by 29
Related Papers
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease
|Journal of the American College of Cardiology|2024|230
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
|International Journal of Radiation Oncology*Biology*Physics|2020|111
Preoperative Frailty Increases Risk of Nonhome Discharge after Elective Vascular Surgery in Home-Dwelling Patients
|Annals of Vascular Surgery|2016|96
High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization
|Journal of Vascular Surgery|2017|82